News

Latest News:

MC2 Biotek becomes MC2 Therapeutics

POSTED: December 15, 2016

MC2 Biotek, a clinical stage emerging specialty pharmaceutical company focusing on dermatology and ophthalmology, today announced that it has changed its name to MC2 Therapeutics.

Jesper J. Lange, President of MC2 ...

READ FULL ARTICLE >

EMA Paediatric Committee (PDCO) granted a waiver for MC2-03 PAD ™ Eye Drop

POSTED: September 29, 2016

Acceptance of this waiver for the Paediatric Investigation Plan (PIP) paves the way for the potential submission of a Marketing Authorization Application (MAA) in Europe following completion of the ongoing ...

READ FULL ARTICLE >

MC2 Biotek to present at ARVO

POSTED: May 1, 2016

MC2 Biotek, a clinical stage specialty pharmaceutical company focused on the development and commercialization of topical drugs that addresses the major problem of non-compliance of otherwise highly efficacious ...

READ FULL ARTICLE >

Upcoming Events:

February 28th, 2022

MC2 exposure at PCMA Business Forum 2022

READ MORE >

August 11th, 2021

MC2 Therapeutics is proud to support National Psoriasis Action Month

READ MORE >

July 23, 2021

MC2 Therapeutics supports World Sjögren’s Day

READ MORE >